RECENT NEWS
TheStreet.com  3 hrs ago  Comment 
NEW YORK (TheStreet) -- Shares ofaValeant Pharmaceuticalsa were up 2.34% to $127.69 in morning trading Tuesday afteraBMO Capital Marketsaincreased its price target on the stock to $176, increased its estimates and maintained its "outperform"...
Motley Fool  3 hrs ago  Comment 
Valeant's third quarter results were convincing -- and well-received
newratings.com  Oct 21  Comment 
BRUSSELS (dpa-AFX) - Specialty pharmaceutical company Actavis plc (ACT) is said to be among the bidders for Belgian consumer health-care company Omega Pharma NV as it continues to look for more acquisition, according to a Bloomberg report on...
Forbes  Oct 21  Comment 
This past weekend, I attended a private dinner for Frederik Paulsen, Jr. at The Explorers Club in New York. The chief executive of Ferring Pharmaceuticals (St. Prex, Switzerland), who is worth an estimated $5 billion, had just received the...
Benzinga  Oct 20  Comment 
Shares of Vitae Pharmaceuticals Inc (NASDAQ: VTAE) are up sharply in Monday’s session following the sell-side lock-up expiration. Amid the expiration, multiple analysts initiated coverage on shares of Vitae: JMP Securities: Market...
TheStreet.com  Oct 20  Comment 
NEW YORK (TheStreet) -- Valeant Pharmaceuticals and Allergan are higher on Monday thanks to Valeant reporting good earnings andasayingait is considering raising its bid for Allergan. Jim Cramer, the co-manager of the Action Alerts PLUS...
Benzinga  Oct 20  Comment 
Valeant Pharmaceuticals International (NYSE: VRX) reported stronger-than-expected earnings for the third quarter and lifted its earnings forecast. The Laval, Canada-based company posted quarterly earnings of $275.4 million, or $0.81 per share,...
The Hindu Business Line  Oct 20  Comment 
Drug firm Alembic Pharmaceuticals today reported 25.35 per cent increase in consolidated net profit after tax and share of profit of associates to Rs 77.27 crore for the second quarter ended Septe...
SeekingAlpha  Oct 17  Comment 
By Don Dion: Xenon Pharmaceuticals (Pending:XENE) recently filed with the Securities and Exchange Commission (SEC) for an IPO with plans to list on NASDAQ. At a target high of $12 for 4 million + shares, the company can potentially raise nearly...




 

This is a list of sub-industries in the pharmaceuticals industry, and a list of their member companies



Drug Delivery

Drug Manufacturers - Major

Drug Manufacturers - Other

Drug Related Products

Biotechnology

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki